Daniel Lightell

487 total citations
12 papers, 404 citations indexed

About

Daniel Lightell is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Daniel Lightell has authored 12 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Surgery and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Daniel Lightell's work include Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (3 papers) and Cardiovascular Disease and Adiposity (2 papers). Daniel Lightell is often cited by papers focused on Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (3 papers) and Cardiovascular Disease and Adiposity (2 papers). Daniel Lightell collaborates with scholars based in United States and Italy. Daniel Lightell's co-authors include T. Cooper Woods, Hernan A. Bazán, Patrick E. Parrino, Michael Bates, Steven O. Marx, Andrew R. Marks, Heng Yu, John T. Paige, Kara L. Spiller and Corey K. Goldman and has published in prestigious journals such as Journal of Biological Chemistry, Stroke and Endocrinology.

In The Last Decade

Daniel Lightell

12 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Lightell United States 10 281 219 70 67 56 12 404
S. Welten Netherlands 11 393 1.4× 285 1.3× 74 1.1× 32 0.5× 76 1.4× 13 508
Ilaria Burba Italy 7 179 0.6× 109 0.5× 72 1.0× 57 0.9× 51 0.9× 10 352
Rachel Simmons United States 6 243 0.9× 167 0.8× 45 0.6× 66 1.0× 83 1.5× 6 396
A.J.N.M. Bastiaansen Netherlands 10 282 1.0× 121 0.6× 118 1.7× 27 0.4× 105 1.9× 11 433
Angel Soto‐Hermida Spain 13 302 1.1× 120 0.5× 35 0.5× 33 0.5× 37 0.7× 17 539
Qunchao Ma China 7 287 1.0× 163 0.7× 67 1.0× 87 1.3× 34 0.6× 14 403
Liujun Jiang China 11 192 0.7× 91 0.4× 47 0.7× 66 1.0× 50 0.9× 24 354
Sufen Guo China 14 257 0.9× 143 0.7× 91 1.3× 51 0.8× 21 0.4× 16 391
Vladislav Miscianinov United Kingdom 5 216 0.8× 156 0.7× 24 0.3× 36 0.5× 47 0.8× 7 334
Sabine Krull Germany 7 183 0.7× 147 0.7× 34 0.5× 62 0.9× 18 0.3× 7 345

Countries citing papers authored by Daniel Lightell

Since Specialization
Citations

This map shows the geographic impact of Daniel Lightell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lightell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lightell more than expected).

Fields of papers citing papers by Daniel Lightell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Lightell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lightell. The network helps show where Daniel Lightell may publish in the future.

Co-authorship network of co-authors of Daniel Lightell

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Lightell. A scholar is included among the top collaborators of Daniel Lightell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Lightell. Daniel Lightell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Yu, Heng, et al.. (2023). Diabetes is accompanied by secretion of pro-atherosclerotic exosomes from vascular smooth muscle cells. Cardiovascular Diabetology. 22(1). 112–112. 18 indexed citations
2.
Paige, John T., et al.. (2019). Modulation of Inflammation in Wounds of Diabetic Patients Treated with Porcine Urinary Bladder Matrix. Regenerative Medicine. 14(4). 269–277. 22 indexed citations
4.
Bazán, Hernan A., et al.. (2017). Carotid Plaque Rupture Is Accompanied by an Increase in the Ratio of Serum circR-284 to miR-221 Levels. Circulation Cardiovascular Genetics. 10(4). 91 indexed citations
5.
Bazán, Hernan A., et al.. (2015). Acute Loss of miR-221 and miR-222 in the Atherosclerotic Plaque Shoulder Accompanies Plaque Rupture. Stroke. 46(11). 3285–3287. 65 indexed citations
6.
Bazán, Hernan A., Daniel Lightell, W. Charles Sternbergh, & T. Cooper Woods. (2014). Abstract 123: Recently Ruptured Carotid Plaques Have Increased Levels of Circular RNA-16, Which Negatively Regulates the Proproliferative and Antiapoptotic MicroRNA-221: A Novel Mediator of Carotid Plaque Rupture. Arteriosclerosis Thrombosis and Vascular Biology. 34(suppl_1). 3 indexed citations
7.
Lightell, Daniel, et al.. (2013). Elevation of miR-221 and -222 in the internal mammary arteries of diabetic subjects and normalization with metformin. Molecular and Cellular Endocrinology. 374(1-2). 125–129. 64 indexed citations
8.
Lightell, Daniel & T. Cooper Woods. (2013). Relative resistance to Mammalian target of rapamycin inhibition in vascular smooth muscle cells of diabetic donors.. PubMed. 13(1). 56–60. 18 indexed citations
9.
Lightell, Daniel, et al.. (2012). Elevated Serum Bone Morphogenetic Protein 4 in Patients with Chronic Kidney Disease and Coronary Artery Disease. Journal of Cardiovascular Translational Research. 6(2). 232–238. 11 indexed citations
10.
Lightell, Daniel, et al.. (2010). Rapamycin Regulates Endothelial Cell Migration through Regulation of the Cyclin-dependent Kinase Inhibitor p27Kip1. Journal of Biological Chemistry. 285(16). 11991–11997. 50 indexed citations
11.
12.
Lightell, Daniel, et al.. (2009). Sera From Patients With Diabetes Do Not Alter the Effect of Mammalian Target of Rapamycin Inhibition on Smooth Muscle Cell Proliferation. Journal of Cardiovascular Pharmacology. 53(1). 86–89. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026